Head and Neck Cancer Trial, Recruiting (NCT06636188)

Head and Neck Cancer Trial, Recruiting NCT06636188 Sponsor: The University of Hong Kong Condition: Head and Neck Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06636188 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Head And Neck Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 or older
People who can read and speak Cantonese or Mandarin fluently
People who have recently received a first-time, primary diagnosis of head and neck or laryngeal (voice box) cancer
People who are waiting to receive a full course of radiation therapy aimed at curing their cancer, with or without chemotherapy
People who are able to carry out normal daily activities to a reasonable degree, as measured by a standard health scoring tool called the Karnofsky performance scale (a score of 70 or above) (confirm with trial site)
People who are experiencing a moderate to high level of emotional distress, as measured by a standard screening tool called the NCCN Distress Thermometer (a score of 3 or above out of 10)

Who may not be able to join:

People who do not have sufficient ability to communicate in Chinese (Cantonese or Mandarin)
People who have any other circumstances that would make it difficult for them to give informed consent or follow the trial's requirements (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tongyao Wang, PhD, The University of Hong Kong

Phone: 852-39102790

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06636188

Sponsor: The University of Hong Kong

Phase: Not Applicable

Status: Recruiting

Condition: Head and Neck Cancer

Trial contact: 852-39102790

More information: https://clinicaltrials.gov/study/NCT06636188

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 or older
People who can read and speak Cantonese or Mandarin fluently
People who have recently received a first-time, primary diagnosis of head and neck or laryngeal (voice box) cancer
People who are waiting to receive a full course of radiation therapy aimed at curing their cancer, with or without chemotherapy
People who are able to carry out normal daily activities to a reasonable degree, as measured by a standard health scoring tool called the Karnofsky performance scale (a score of 70 or above) (confirm with trial site)
People who are experiencing a moderate to high level of emotional distress, as measured by a standard screening tool called the NCCN Distress Thermometer (a score of 3 or above out of 10)

Who may not be able to join:

People who do not have sufficient ability to communicate in Chinese (Cantonese or Mandarin)
People who have any other circumstances that would make it difficult for them to give informed consent or follow the trial's requirements (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The University of Hong Kong

Registry

ClinicalTrials.gov

Start date

1 February 2026

Est. completion

1 November 2027

Where this trial is recruiting

Hong Kong

Primary endpoints

National Comprehensive Cancer Network Distress Thermometer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov